AbCellera Biologics Inc. reports

Location
2215 Yukon Street, Vancouver, British Columbia, Canada
State of incorporation
British Columbia, Canada
Fiscal year end
December 31
Data updated at
8/30/2024, 01:35 AM
Form type Sec Links Description Filing date Reporting date
10-Q Report | Data 10-Q Aug 6, 2024 Jun 30, 2024
8-K Report | Data 8-K Aug 6, 2024 Aug 6, 2024
8-K Report | Data 8-K Jun 13, 2024 Jun 13, 2024
10-Q Report | Data 10-Q May 7, 2024 Mar 31, 2024
8-K Report | Data 8-K May 7, 2024 May 7, 2024
8-K Report | Data 8-K Feb 23, 2024 Feb 16, 2024
10-K Report | Data 10-K Feb 20, 2024 Dec 31, 2023
8-K Report | Data 8-K Feb 20, 2024 Feb 20, 2024
SC 13G Report SC 13G Feb 14, 2024
SC 13G/A Report SC 13G/A Feb 13, 2024
SC 13G/A Report Jan 29, 2024
8-K Report | Data 8-K Nov 28, 2023 Nov 28, 2023
10-Q Report | Data 10-Q Nov 2, 2023 Sep 30, 2023
8-K Report | Data 8-K Nov 2, 2023 Nov 2, 2023
8-K Report | Data 8-K Oct 13, 2023 Sep 18, 2023
10-Q Report | Data 10-Q Aug 3, 2023 Jun 30, 2023
8-K Report | Data 8-K Aug 3, 2023 Aug 3, 2023
8-K Report | Data 8-K Jun 20, 2023 Jun 15, 2023
8-K Report | Data 8-K May 24, 2023 May 24, 2023
10-Q Report | Data 10-Q May 4, 2023 Mar 31, 2023
8-K Report | Data 8-K May 4, 2023 May 4, 2023
SC 13D/A Report SC 13D/A Apr 24, 2023
8-K Report | Data 8-K Mar 13, 2023 Mar 10, 2023
10-K Report | Data 10-K Feb 21, 2023 Dec 31, 2022
8-K Report | Data 8-K Feb 21, 2023 Feb 21, 2023
SC 13G/A Report SEC SCHEDULE 13G Feb 13, 2023
SC 13G/A Report SC 13G/A Feb 6, 2023
SC 13G Report Jan 18, 2023
10-Q Report | Data 10-Q Nov 8, 2022 Sep 30, 2022
8-K Report | Data 8-K Nov 8, 2022 Nov 8, 2022
10-Q Report | Data 10-Q Aug 9, 2022 Jun 30, 2022
8-K Report | Data 8-K Aug 9, 2022 Aug 9, 2022
10-K/A Report | Data 10-K/A Jul 22, 2022 Dec 31, 2021
8-K Report | Data 8-K Jul 19, 2022 Jul 9, 2022
8-K Report | Data 8-K Jul 6, 2022 Jun 29, 2022
8-K Report | Data 8-K Jun 30, 2022 Jun 29, 2022
8-K Report | Data 8-K Jun 21, 2022 Jun 15, 2022
10-Q Report | Data 10-Q May 10, 2022 Mar 31, 2022
8-K Report | Data 8-K May 10, 2022 May 10, 2022
10-K Report | Data 10-K Feb 25, 2022 Dec 31, 2021
8-K Report | Data 8-K 2021 10K Feb 24, 2022 Feb 24, 2022
8-K Report | Data 8-K Feb 15, 2022 Feb 11, 2022
SC 13G/A Report SC 13GA Feb 14, 2022
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G Report SEC SCHEDULE 13G Feb 11, 2022
SC 13G/A Report SC 13G/A Feb 10, 2022
8-K Report | Data 8-K Dec 7, 2021 Dec 7, 2021
8-K Report | Data 8-K Dec 3, 2021 Dec 2, 2021
10-Q Report | Data 10-Q Nov 10, 2021 Sep 30, 2021
8-K Report | Data 8-K Nov 9, 2021 Nov 9, 2021
8-K Report | Data 8-K Nov 4, 2021 Nov 2, 2021
8-K Report | Data 8-K Sep 23, 2021 Sep 21, 2021
8-K Report | Data 8-K Sep 15, 2021 Sep 13, 2021
10-Q Report | Data 10-Q Aug 13, 2021 Jun 30, 2021
8-K Report 8-K Aug 12, 2021 Aug 12, 2021
8-K Report 8-K Jul 13, 2021 Jul 13, 2021
8-K Report 8-K Jun 21, 2021 Jun 15, 2021
8-K/A Report 8-K/A May 17, 2021 May 13, 2021
10-Q Report | Data 10-Q May 14, 2021 Mar 31, 2021
8-K Report 8-K May 13, 2021 May 13, 2021
8-K Report 8-K Apr 1, 2021 Apr 1, 2021
10-K Report 10-K Mar 30, 2021 Dec 31, 2020
8-K Report 8-K Mar 29, 2021 Mar 29, 2021
8-K Report 8-K Mar 2, 2021 Feb 26, 2021
SC 13G Report SC 13G Feb 16, 2021
SC 13G/A Report AMENDMENT NO. 2 Feb 16, 2021
SC 13G Report SC 13G Feb 9, 2021
SC 13D Report ABCELLERA BIOLOGICS INC. SCHEDULE 13D Dec 28, 2020
SC 13G/A Report AMENDMENT TO FORM SC 13G Dec 28, 2020
SC 13G Report ACQUISITION OF BENEFICIAL OWNERSHIP Dec 21, 2020